Pieris Pharmaceuticals Inc (NAS:PIRS)
$ 10.97 -0.28 (-2.49%) Market Cap: 13.57 Mil Enterprise Value: -12.80 Mil PE Ratio: 0 PB Ratio: 0.51 GF Score: 48/100

Full Year 2018 Pieris Pharmaceuticals Inc Earnings Call Transcript

Mar 12, 2019 / 12:00PM GMT
Release Date Price: $256.8 (+3.55%)
Operator

Greetings, and welcome to the Pieris Pharmaceuticals 2018 Fourth Quarter and Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Allan Reine, Chief Financial Officer for Pieris Pharmaceuticals. Thank you. Mr. Reine, you may begin.

Allan Reine
Pieris Pharmaceuticals, Inc. - Senior VP, CFO & Treasurer

Good morning, everyone, and thank you for joining us for our year-end 2018 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO; and Lou Matis, SVP and Chief Development Officer, who will be available for Q&A. You can access the press release released this morning on the Investor Relations page of our website at www.pieris.com.

Before we begin, I'd like to caution that comments made during this call may contain forward-looking statements involving risks and uncertainties regarding the operations and future results of operations of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot